(Q43839578)

27 November 2017

title

Expression of galectin-3 in pancreatic ductal adenocarcinoma (English)

1 reference

27 November 2017

1 reference

10

Moritz N Wente

1 reference

27 November 2017

6

Thilo Welsch

1 reference

27 November 2017

Matthias M Gaida

1

1 reference

27 November 2017

Sylvia T Bach

2

1 reference

27 November 2017

Frank Günther

3

1 reference

27 November 2017

Billur Baseras

4

1 reference

27 November 2017

Darjus F Tschaharganeh

5

1 reference

27 November 2017

Klaus Felix

7

1 reference

27 November 2017

Frank Bergmann

8

1 reference

27 November 2017

Gertrud M Hänsch

9

1 reference

27 November 2017

publication date

12 September 2011

1 reference

Pathology Oncology Research

27 November 2017

published in

1 reference

27 November 2017

volume

18

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

299-307

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9444-1

27 November 2017

1 reference

Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9444-1

Concerted regulation of focal adhesion dynamics by galectin-3 and tyrosine-phosphorylated caveolin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9444-1

Upregulation of galectins-1 and -3 in human colon cancer and their role in regulating cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9444-1

Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9444-1

Galectin-3 expression is associated with bladder cancer progression and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9444-1

Galectins: structure, function and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9444-1

Galectin-3: an open-ended story

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9444-1

The role of galectin-3 in promotion of the inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9444-1

Galectin-3 in cardiac remodeling and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9444-1

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9444-1

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9444-1

Clinical significance of Galectin-3 in clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9444-1

Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9444-1

Solid and pseudopapillary tumor of the pancreas--review and new insights into pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9444-1

Expression pattern and functional relevance of epidermal growth factor receptor and cyclooxygenase-2: novel chemotherapeutic targets in pancreatic endocrine tumors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9444-1

The neurotrophic factor artemin influences the extent of neural damage and growth in chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9444-1

Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9444-1

Galectin-3 Expression Is Associated with Tumor Progression and Pattern of Sun Exposure in Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9444-1

Clinicopathological significance of galectin-3 expression in ductal adenocarcinoma of the pancreas

21 January 2018

1 reference

12 December 2020

Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications

1 reference

12 December 2020

1 reference

12 December 2020

Serum level of galectin-3 in human bladder cancer

1 reference

12 December 2020

Galectin-3 and proliferating cell nuclear antigen (PCNA) expression in papillary thyroid carcinoma

1 reference

12 December 2020

Cancer statistics, 2010

1 reference

12 December 2020

Clinical significance of the expression of galectin-3 and Pim-1 in laryngeal squamous cell carcinoma

1 reference

12 December 2020

Serum Galectin-1 and Galectin-3 Levels in Benign and Malignant Nodular Thyroid Disease

1 reference

12 December 2020

Galectin-1 and galectin-3 in chronic pancreatitis

1 reference

12 December 2020

Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer

1 reference

12 December 2020

Immunoexpression of galectin-3 in colorectal cancer and its relationship with survival.

1 reference

12 December 2020

Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma

1 reference

12 December 2020

10.1007/S12253-011-9444-1

Identifiers

DOI

1 reference

27 November 2017

1 reference